Hemagen Diagnostics, Inc. (OTCPK: HMGN)
Health Care · Health Care Equipment & Supplies · US
$—
— today · — 1Y
Hemagen Diagnostics, Inc. (OTCPK: HMGN) operates in the Health Care Equipment & Supplies industry within the Health Care sector. The company is valued at $3.10K and employs 15 people.
trading between 0.00 and 0.13.
Tweenvest scores Hemagen Diagnostics, Inc. across four factors: quality 27/100, value 51/100. Its strongest factor is value.
HMGN price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $3.10K
- Revenue (TTM)
- $4.04M
- P/E
- —
- EPS
- -0.06
- Dividend yield
- —
- Beta (5Y)
- 1,150.59
- 52-week high
- $0.13
- 52-week low
- $0.00
- Avg volume (3M)
- —
- Shares outstanding
- 15.50M
- Employees
- 15
- Next earnings
- —
About Hemagen Diagnostics, Inc.
Hemagen Diagnostics, Inc., a global biotechnology firm, specializes in delivering clinical diagnostic solutions for both human and animal health. The company designs, manufactures, and distributes the VIRGO product line, a series of human clinical immunoassays used for identifying autoimmune and infectious diseases, as well as acute phase proteins. Its comprehensive human diagnostic portfolio also encompasses Universal IFA components, various supplies, controls, calibrators, accessories, H-rotors, reagents, electrodes, equipment, and specialized assays covering conditions such as Chagas, acute phase proteins, and cytokines. For the veterinary market, Hemagen Diagnostics provides diagnostic equipment, reagents, consumables, accessories, and electrodes crucial for chemistry, hematology, and electrolyte analysis. The company reaches a diverse customer base, including laboratories, hospitals, and blood banks, through both direct sales and an extensive distribution network. Established in 1985, Hemagen Diagnostics maintains its headquarters in Columbia, Maryland.
- ISIN
- US4235011057
- Founded
- 1985
- Listed since
- Feb 4, 1993
- Exchange
- Pink Sheets LLC
- Currency
- USD
Other Health Care Equipment & Supplies companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Abbott LaboratoriesNYSE: ABT | $201.88B | $116.13 | -0.46% |
| Intuitive Surgical, Inc.NasdaqGS: ISRG | $131.97B | $371.84 | -0.46% |
| Stryker CorporationNYSE: SYK | $125.74B | $330.59 | +0.85% |
| Medtronic plcNYSE: MDT | $118.91B | $91.14 | -1.89% |
| EssilorLuxottica Société anonymeENXTPA: EL | $86.72B | €159.15 | -1.58% |
| Boston Scientific CorporationNYSE: BSX | $71.03B | $49.86 | +1.73% |
| Siemens Healthineers AGXTRA: SHL | $52.46B | €39.70 | -1.71% |
| HOYA CorporationTSE: 7741 | $52.35B | ¥24,895.00 | -1.37% |
Figures last refreshed Aug 18, 2026.